You are here

A Prospective, International, Multicenter, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Alone or Combined with Hyaluronic Acid (HA) Chronic Discogenic Lumbar Back Pain

Description 
Phase 3 - A Prospective, International, Multicenter, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Alone or Combined with Hyaluronic Acid (HA) in Subjects with Chronic Discogenic Lumbar Back Pain
Essential criteria: 
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords 
Neurosurgery, research, [A/Prof, Tony Goldschlager], Prospective, International, Multicenter, Randomised, Double-Blind, Placebo-Controlled, Single Injection, Rexlemestrocel-L, Hyaluronic Acid (HA), Chronic, Discogenic, Lumbar, Back Pain
School 
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research » Surgery - Monash Medical Centre
Available options 
PhD/Doctorate
Masters by research
Time commitment 
Full-time
Part-time
Top-up scholarship funding available 
No
Physical location 
Monash Health Translation Precinct (Monash Medical Centre)
Co-supervisors 
Adj Clin Assoc Prof 
Tony Goldschlager

Want to apply for this project? Submit an Expression of Interest by clicking on Contact the researcher.